The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

NCT00216866 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborators